Crossmark Global Holdings’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,062
Closed -$206K 1332
2023
Q2
$206K Buy
2,062
+38
+2% +$3.8K ﹤0.01% 1244
2023
Q1
$221K Buy
2,024
+191
+10% +$20.9K 0.01% 1182
2022
Q4
$209K Buy
+1,833
New +$209K 0.01% 1185
2022
Q2
Sell
-2,135
Closed -$225K 1364
2022
Q1
$225K Buy
+2,135
New +$225K 0.01% 1258
2021
Q4
Sell
-7,315
Closed -$801K 1502
2021
Q3
$801K Buy
+7,315
New +$801K 0.02% 689